+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Health Equity and Inclusiveness Research Fellow Award

LUNGevity Foundation

The 2026 LUNGevity Health Equity and Inclusiveness Research Fellow Award program is now open for application submissions.

LUNGevity Health Equity and Inclusiveness Research Fellow Awards support physician-scientists interested in conducting lung cancer clinical research and bridging health disparities by engaging underserved communities or underrepresented minorities. Projects funded in 2026 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.

Award Guidelines

Applicants must hold a doctoral degree, be in any year of a fellowship, and plan to pursue a career in lung cancer.
The award is a mentored award; a mentoring plan is part of the required submission.
Awards may be for a maximum of $100,000 ($50,000 per year for 2 years).
Annual milestones must be met.

Note: LUNGevity will grant only one Health Equity and Inclusiveness Research Fellow Award per institution.

LUNGevity uses a two-step application process:

A letter of intent (LOI), with a brief overview of the proposed project and biographical information
A full application with an extended narrative about the project, as well as supporting information and documentation. (Because there are a limited number of awards, only a subset of applicants will be invited to submit a full application after the LOI review is completed.)

Reviewers are drawn from LUNGevity’s Scientific Advisory Board and other lung cancer experts. Awardees have progress and financial reporting obligations during their award term.

A complete description of the award, terms and conditions, and instructions are included in the 2026 LUNGevity Health Equity and Inclusiveness Research Fellow Award RFA. All application materials must be submitted via proposalCENTRAL.

2026 Health Equity and Inclusiveness Research Fellow Award Timeline

LOIs due:		February 17, 2026, 11:59 pm EST
Invitations to apply:		No earlier than March 30, 2026
Applications due:		May 11, 2026, 11:59 pm EDT
Award announcement:		Late summer 2026
Award start date:		November 1, 2026

AI Based Application Success Predictor

Based on funded programs and priorities:

🥇 1. Strong Lung Cancer Focus (Top Predictor)

Must clearly address:
- Lung cancer biology
- Diagnosis
- Treatment

✔ Mandatory disease relevance

🥈 2. Innovation (Highly Weighted)

Strong emphasis on:
- Novel ideas
- High-risk, high-reward research

✔ Competitive proposals introduce:

New mechanisms
New therapeutic strategies

🥉 3. Translational & Clinical Impact

Preference for:
- Research that can impact patients

✔ High success:

Biomarker studies
Targeted therapy development

4. Early Career Investigator Advantage

Many grants target:
- Junior faculty
- Early-stage researchers

✔ Strong mentorship improves success

5. Precision Medicine Focus

Priority areas:
- Genomics
- Personalized treatment

6. Feasibility & Clear Study Design

Must include:
- Realistic timeline
- Achievable objectives

7. Strong Scientific Rationale

Requires:
- Clear hypothesis
- Supporting data

8. Patient Impact & Outcomes

Emphasis on:
- Survival improvement
- Quality of life

🧪 Common Funded Research Areas

Targeted therapies (EGFR, ALK, etc.)
Immunotherapy
Early detection and screening
Biomarkers and precision oncology
Resistance mechanisms
Survivorship research

⚠️ Common Reasons for Rejection

Weak lung cancer focus
Lack of innovation
Poor methodology
No translational relevance
Overly ambitious scope

🧠 Bottom Line (Key Predictors Ranked)

Direct relevance to lung cancer
Innovation (high priority)
Translational/clinical impact
Strong scientific rationale
Feasible, well-designed study
Patient-centered outcomes

Specialties

Public Health

Pulmonology

Eligibility Requirements

Applicants must hold a doctoral degree, be in any year of a fellowship, and plan to pursue a career in lung cancer.
The award is a mentored award; a mentoring plan is part of the required submission.
Awards may be for a maximum of $100,000 ($50,000 per year for 2 years).
Annual milestones must be met.

Sponsor Details

Sponsor Institute/Organizations: LUNGevity Foundation

Sponsor Type: Corporate/Non-Profit

Address: PO Box 754, Chicago, IL 60690 info@lungevity.org

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity